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and a corScosteroid (Fluticasone Propionate) on human airway 
epithelial cells following Staphylococcus aureus infecSon 
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Staphylococcus aureus (S. aureus) ir a major cause of pulmonary infection, 
frequently involved in early airway infection in CF patients. We invertigated the 
effect of S. aureus oluble virulence factors (VF) on i lff lammation and junctional 
propertier of human airway epithelial cells, mad further analyzed the anti 
i lfflammatory effect of Salmeterol (Sal) and Fluticar one Pr opionate (FP). 
We firrt incubated the human tracheal glandular cell l ine (MM39) with Sal 
(2.1(UM), FP (1.101M) or their combination for 16 hours, then added a 20% 
rupernatant culture of S. aureus rtrain 8325 4 for 0.5, 1, 2, 3 and 4b. IL  8, IL 6, 
TNFc~ mad PGE2 releare war meas~ared by ELISA tert on cell culture rupernat ant r, 
IL  8 and TNFo: mRNA exprer ion by RT PCR, NF kB activity by EMSA,  c~cludin 
and Zonula occIudens 1 (ZO 1) protein exprerr ion by Wertern Blot mad immuno 
fluorercence. 
From 0.5h up to 4b of interaction between S. aureus VF and MM39 cellr, we  
obrerved a progrerrive degradation of c~cludin and ZO 1, associated with an 
increare (P<0.C()I) of IL 8 and TNFo: mRNA exprerrion, NF kB activity (P<0.05) 
and IL  8, IL 6, TNFo: and PGE2 releare (P<0.05). In contrart, ha MM39 cellr pre 
incubated with Sal mad FP, we  obrerved a decreare of IL  8 (P<0.C()I) and TNFo: 
(P<0.05) mRNA exprer ion after lh  of S. aureus VF incubation, associated after 3 h 
with a decreare (P<0.05) of IL  8, IL  6 and TNFo: releare. 
There rerultr emphasize the deleteriour effect of S. aureus roluble virulence factorr 
and demonstrate that Sal and FP attenuate the hfflammatory rerponre in airway 
epithelial cellr. 
Supported by INSERM, GlaxoSmithKl ine  mad Association Vaincre la 
Mucovircidore. 
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Aims: The human airway tt3,prin l ike proteare (HAT) ir a recently identified, type 
II tranrmembrane r f ine proteare ndowed with a trypsin l ike enzymatic activity. 
HAT which ir rynthetized by cil iated bronchial epithelial cells, can be detected ar a 
major soluble active enzyme ha the sputum of patients with chronic airway 
ilfflammatot3~ disorders mad might thur be involved in (patho)pbyriological 
mechanirmr through the modulation of cellular and/or extracellular p oteinr. 
Our project war  to evaluate the capacity of HAT to alter the slructure and functionr 
of the 3<lomainr u okinare receptor (CD87/uPAR), which participater to imaate 
immunity and inf lammation by rupporting cell migration and matrix degradation, 
and which can be regulated tbr ough endoproteolyrir. 
Methods a~ul results: Tbrough immunoblotting and ELISA analyrir applied to a 
recombinant uPAR protein and to human bronchial epithelial cel lr  ar wel l  ar 
monc~yter, we  demonrtrate that exporure to HAT rerultr in the proteolytic 
prccerr ing of the intact (D1D2D3) uPAR into a tt~acated (D2D3) fragment. Thir 
prccerr ing modifier the receptor functionr ince removal of domain D1 maker the 
receptor unable to bind anymore two f itr major l igandr, the adherive protein 
vitr onectin mad the refine pr oteare ur okinare. 
Conclusion: Such apr  oteolytic modulation of uPAR ir l ikely to alter the motil ity of 
cellr and the remodeling of tirruer, and could thur participate to the regulation of 
the inflammatory rerponre. 
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Aims: This ir  the first study to measure inducible nitric oxide rynthare xpression 
quantitatively in primary epithelial cells from very young children with cystic 
fibrosis (CF). 
Methods: Cells were obtained by tracheo bronchial bmrbing in 40 children with 
cystic fibrosis (mean age + SD, 2.1 + 1.5 yearr) mad 13 healthy, non atopic contr olr 
(3.4 + 1.2 yearr) and expression of iNOS war mearured using quantitative PCR 
(TaqMma®) relative to the expression of 13 actin. 
Results: No difference in expression of iNOS war found ha CF patients with mad 
without bacterial colonization ha broncho alveolar lavage (BAL) (0.22 vr 0.23) 
however, iNOS expression war rignif icantly lower ha CF patients than in healthy 
children (0.75 ;P~) .003 for colonized and P 0.009 for non-colonized CF patients). 
There war  a borderline rignificant increare of iNOS exprer ion with age in the CF 
patientr, whereat gender, weight and genotype did not influence the exprerrion of
NOS. NOS exprerrion war independent of the cellular componentr of BAL  ha the 
children with CF. 
Conclusions: There res~alt r ruppor t the f indingr of previour tudier in adult patient r 
with advanced direare, cell l iner and animal modelr. Our f indingr reflect the 
rituation in young children without advanced ireare. They indicate that low iNOS 
exprer ion may be an imaate defect with potentially important conrequencer for the 
local anti microbial defenre and ruggert implicationr for a new therapeutic 
approach. 
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Elastase-related proteases in cystic f ibrosis sputum 
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Unoppored proteolytic activity in rputum or BAL  fluid i ra  char acterir t c feature of 
CF. Protease targeting by inhibitorr appearr therefore ar an attracting rtrategy to 
treat inf lammation and porribly bacterial proliferation in CF. Rerultr  however 
remained l imited until now. One rearon could be that effortr mainly focured on 
neutr ophil e lartare (FINE) and not on related protearer s~ach ar pr otease 3 (Pr3) and 
catheprin G (Cat G) though there protearer are rtored in r imi lar amountr in 
neutr ophil primary gr anuler and are recreted at the tame t ime by activated cellr. The 
contribution of individual protearer to the pathogenicity in CF hat not been 
evaluated becaure of the lack unti l  recently of highly rpecific and renrit ive 
rubrtrater that al low to mearure individual protearer activitier in rputum or in BAL  
fluid of CF patient r.
We faired a serier of rpecific and renrit ive s~abrtrater bared on the S' rpecificity of 
there protearer (i.e. protearer rubriter that accommodate rubrtrate reriduer 
downrtream the cleavage rite). Those allow to dircriminate between the activitier 
of all flaree protearer, erpecially thore of HNE and Pr3 that rhare very r imilar 
rpecificitier. Protearer activitier in the r oluble phase mad at the rurface of activated 
cellr in rputum were meas~ared and the partition of each proteare between the 
r oluble and the rol id phare war  determined. 
Since proteare activitier in the roluble fraction and in the rolid phase could be 
differently regulated, we  alto mearured the rater of inhibition of roluble mad 
membrane bound protearer by natural and recombinant inhibit or r. 
Dircr iminat ing between pr oteare activitier n CF rputum wi l l  be helpful to develop 
new inhibitorr that ppropriately control thore of proteolytic activitier that initiate, 
promote and make chronic lung inf lammation and infection during CF. 
